Interaction	interaction	O	O
of	of	O	O
cyclosporin	cyclosporin	B_chemical	O
A	a	I_chemical	O
with	with	O	O
antineoplastic	antineoplastic	B_chemical	O
agents	agents	I_chemical	O
.	.	O	O

A	a	O	O
synergistic	synergistic	O	O
effect	effect	O	O
of	of	O	O
etoposide	etoposide	S_chemical	O
and	and	O	O
cyclosporin	cyclosporin	B_chemical	O
A	a	I_chemical	O
was	was	O	O
observed	observed	O	O
in	in	O	O
a	a	O	O
patient	patient	O	O
with	with	O	O
acute	acute	O	B_disease
T-lymphocytic	t-lymphocytic	O	I_disease
leukemia	leukemia	O	I_disease
in	in	O	O
relapse	relapse	O	O
.	.	O	O

The	the	O	O
concomitant	concomitant	O	O
administration	administration	O	O
of	of	O	O
etoposide	etoposide	S_chemical	O
and	and	O	O
cyclosporin	cyclosporin	B_chemical	O
A	a	I_chemical	O
resulted	resulted	O	O
in	in	O	O
eradication	eradication	O	O
of	of	O	O
hitherto	hitherto	O	O
refractory	refractory	O	O
leukemic	leukemic	O	B_disease
infiltration	infiltration	O	I_disease
of	of	O	O
bone	bone	O	B_disease
marrow	marrow	O	I_disease
.	.	O	O

Severe	severe	O	O
side	side	O	B_disease
effects	effects	O	I_disease
in	in	O	O
terms	terms	O	O
of	of	O	O
mental	mental	O	O
confusion	confusion	O	S_disease
and	and	O	O
progressive	progressive	O	O
hyperbilirubinemia	hyperbilirubinemia	O	O
,	,	O	O
however	however	O	O
,	,	O	O
point	point	O	O
to	to	O	O
an	an	O	O
enhancement	enhancement	O	O
not	not	O	O
only	only	O	O
of	of	O	O
antineoplastic	antineoplastic	O	O
effects	effects	O	O
but	but	O	O
also	also	O	O
of	of	O	O
toxicity	toxicity	O	S_disease
in	in	O	O
normal	normal	O	O
tissues	tissues	O	O
.	.	O	O

This	this	O	O
report	report	O	O
demonstrates	demonstrates	O	O
for	for	O	O
the	the	O	O
first	first	O	O
time	time	O	O
that	that	O	O
the	the	O	O
pharmacodynamic	pharmacodynamic	O	O
properties	properties	O	O
of	of	O	O
cyclosporin	cyclosporin	B_chemical	O
A	a	I_chemical	O
may	may	O	O
not	not	O	O
be	be	O	O
confined	confined	O	O
strictly	strictly	O	O
to	to	O	O
suppression	suppression	O	O
of	of	O	O
normal	normal	O	O
T-cell	t-cell	O	O
functions	functions	O	O
.	.	O	O

